ArticleOncoTargets and therapy2016

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine.

Stefan Wittke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.